Effects of maternal diabetes on trophoblast cells.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 4360428)

Published in World J Diabetes on March 15, 2015

Authors

Marlúcia Bastos Aires1, Anne Carolline Veríssimo Dos Santos1

Author Affiliations

1: Marlúcia Bastos Aires, Anne Carolline Veríssimo dos Santos, Department of Morphology, Federal University of Sergipe, São Cristóvão 49100-000, Sergipe, Brazil.

Articles cited by this

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 75.82

Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell (1997) 24.57

Standards of medical care in diabetes--2011. Diabetes Care (2011) 21.94

Standards of medical care in diabetes--2012. Diabetes Care (2012) 20.66

Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell (1998) 16.08

Standards of medical care in diabetes--2009. Diabetes Care (2009) 15.78

The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer (2002) 14.94

Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev (1995) 13.66

FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex. Cell (1996) 12.07

Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell (2000) 11.90

G1 phase progression: cycling on cue. Cell (1994) 11.62

Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell (1995) 9.22

Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J (1995) 7.60

Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell (1991) 6.65

FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem (1996) 3.72

Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci U S A (2002) 3.57

Type 1 diabetes. Lancet (2013) 3.45

Toxic proteins released from mitochondria in cell death. Oncogene (2004) 2.78

The increasing prevalence of diabetes in pregnancy. Obstet Gynecol Clin North Am (2007) 2.45

Cooperation between the Cdk inhibitors p27(KIP1) and p57(KIP2) in the control of tissue growth and development. Genes Dev (1998) 2.39

Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways. Nat Med (1998) 2.29

Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. Hum Reprod Update (2006) 2.15

What is gestational diabetes? Diabetes Care (2007) 2.01

Caspase-10 is an initiator caspase in death receptor signaling. Proc Natl Acad Sci U S A (2001) 1.90

Mediation of cell death by poly(ADP-ribose) polymerase-1. Pharmacol Res (2005) 1.57

Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochem Cell Biol (1998) 1.53

Placental apoptosis in normal human pregnancy. Am J Obstet Gynecol (1997) 1.49

Apoptotic and proliferative activities in first trimester placentae. Placenta (1999) 1.47

The role of apoptosis in the regulation of trophoblast survival and differentiation during pregnancy. Endocr Rev (2005) 1.37

Growth factors, proteases and protease inhibitors in the maternal-fetal dialogue. Placenta (1996) 1.30

Trophoblast apoptosis from pregnancies complicated by fetal growth restriction is associated with enhanced p53 expression. Am J Obstet Gynecol (2002) 1.25

Placental apoptosis in health and disease. Am J Reprod Immunol (2010) 1.25

A potential mechanism of "cross-talk" between the p55 tumor necrosis factor receptor and Fas/APO1: proteins binding to the death domains of the two receptors also bind to each other. J Exp Med (1996) 1.23

Signalling pathways regulating the invasive differentiation of human trophoblasts: a review. Placenta (2005) 1.22

Paracrine and autocrine regulators of trophoblast invasion--a review. Placenta (2000) 1.19

Consequences of gestational and pregestational diabetes on placental function and birth weight. World J Diabetes (2011) 1.12

Location of cell cycle regulators cyclin B1, cyclin A, PCNA, Ki67 and cell cycle inhibitors p21, p27 and p57 in human first trimester placenta and deciduas. Histochem Cell Biol (2006) 1.04

Toxicological pathology in the rat placenta. J Toxicol Pathol (2011) 1.03

Fetal growth and placental function. Mol Cell Endocrinol (1998) 1.02

p57(Kip2) regulates the proper development of labyrinthine and spongiotrophoblasts. Mol Hum Reprod (2000) 1.02

Pattern of expression of cyclin D1/CDK4 complex in human placenta during gestation. Cell Tissue Res (2004) 0.99

Proliferation, differentiation and apoptosis in villous trophoblast at 13-41 weeks of gestation (including observations on annulate lamellae and nuclear pore complexes). Placenta (1999) 0.98

Apoptosis in human chorionic villi and decidua during normal embryonic development and spontaneous abortion in the first trimester. Placenta (1998) 0.97

Controlling cell proliferation in differentiating tissues: genetic analysis of negative regulators of G1-->S-phase progression. Curr Opin Cell Biol (1997) 0.93

Trophoblasts express Fas ligand: a proposed mechanism for immune privilege in placenta and maternal invasion. Mol Hum Reprod (1997) 0.93

A repertoire of cell cycle regulators whose expression is coordinated with human cytotrophoblast differentiation. Am J Pathol (2000) 0.92

Foetal and placental weights in relation to maternal characteristics in gestational diabetes. Placenta (2003) 0.92

A review of maternal and fetal growth factors in diabetic pregnancy. Curr Diabetes Rev (2010) 0.91

Fine structural abnormalities of the placenta in diabetic rats. Diabetes (1986) 0.90

Dysglycemias in pregnancy: from diagnosis to treatment. Brazilian consensus statement. Diabetol Metab Syndr (2010) 0.88

Placental apoptosis in normal and abnormal pregnancies. Gynecol Obstet Invest (2000) 0.88

Gestational diabetes mellitus decreases placental uptake of long-chain polyunsaturated fatty acids: involvement of long-chain acyl-CoA synthetase. J Nutr Biochem (2013) 0.88

Apoptosis is a rare event in first-trimester placental tissue. Am J Obstet Gynecol (2000) 0.87

An ultrastructural and ultrahistochemical study of the placenta of the diabetic woman. J Pathol (1976) 0.85

Effect of maternal age on incidences of apoptotic and proliferative cells in trophoblasts of full-term human placenta. Mol Hum Reprod (2001) 0.85

Pathology of the placenta in maternal diabetes mellitus. Obstet Gynecol (1969) 0.84

Role of the Fas/Fas ligand system in female reproductive organs: survival and apoptosis. Biochem Pharmacol (2002) 0.84

Hyperglycaemia in vitro alters the proliferation and mitochondrial activity of the choriocarcinoma cell lines BeWo, JAR and JEG-3 as models for human first-trimester trophoblast. Diabetologia (2001) 0.84

Influence of maternal diabetes on placental fibroblast growth factor-2 expression, proliferation, and apoptosis. J Soc Gynecol Investig (2004) 0.84

Changes in apoptosis and Bcl-2 expression in human hyperglycemic, term placental trophoblast. Diabetes Res Clin Pract (2006) 0.84

The human blastocyst regulates endometrial epithelial apoptosis in embryonic adhesion. Biol Reprod (2000) 0.84

Vascular endothelial cadherin and beta-catenin in human fetoplacental vessels of pregnancies complicated by Type 1 diabetes: associations with angiogenesis and perturbed barrier function. Diabetologia (2004) 0.83

Maternal diabetes affects specific extracellular matrix components during placentation. J Anat (2007) 0.83

Mapping of CIP/KIP inhibitors, G1 cyclins D1, D3, E and p53 proteins in the rat term placenta. Histochem Cell Biol (2011) 0.81

Histomorphometry of the placenta of the diabetic women: class A diabetes mellitus. Placenta (1981) 0.81

Effect of gestational diabetes and maternal hypertension on gross morphology of placenta. J Ayub Med Coll Abbottabad (2005) 0.81

Changes in proliferative potential, apoptosis and Bcl-2 protein expression in cytotrophoblasts and syncytiotrophoblast in human placenta over the course of pregnancy. Endocr J (2000) 0.81

Expression of proliferation and apoptotic markers in human placenta during pregnancy. Acta Histochem (2002) 0.81

Immunohistochemical distribution of cell cycle proteins p27, p57, cyclin D3, PCNA and Ki67 in normal and diabetic human placentas. J Mol Histol (2013) 0.80

Maternal diabetes affects cell proliferation in developing rat placenta. Histol Histopathol (2011) 0.80

Gestational diabetes mellitus alters apoptotic and inflammatory gene expression of trophobasts from human term placenta. J Diabetes Complications (2014) 0.80

Is there a relationship between PCNA expression and diabetic placental development during pregnancy? Acta Histochem (2008) 0.79

Prenatal ultrasonographic assessment of the ductus arteriosus: a review. Obstet Gynecol (1996) 0.79

Placental effects of systemic tumour necrosis factor-α in an animal model of gestational diabetes mellitus. Placenta (2010) 0.79

Histopathological changes in the placenta of streptozotocin induced diabetic rats. Diabetologia (1974) 0.78

Localization of glycogen in the placenta of diabetic rats: a light and electron microscopic study. Placenta (1987) 0.78

Cell cycle inhibitor p57 expression in normal and diabetic rat placentas during some stages of pregnancy. Histol Histopathol (2012) 0.78

Maternal diabetes affects rat placental morphology and pregnancy. Endocrine (2014) 0.77

Reduced apoptosis in term placentas from gestational diabetic pregnancies. J Dev Orig Health Dis (2013) 0.76